Open AccessEndoscopic Perductal Electrolytic Ablation of the Pancreas: Experimental Studies of Morbidity and Mortality
Author(s) -
Charles Morrison,
Fiona Court,
Benjamin D. Teague,
Matthew S. Metcalfe,
Simon A. WemyssHolden,
Michael Texler,
Ashley R. Dennison,
Guy J. Maddern
Publication year - 2005
Publication title -
digestive diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.879
H-Index - 66
eISSN - 1421-9875
pISSN - 0257-2753
DOI - 10.1159/000084730
Subject(s) - medicine , pancreatic cancer , endoscopic retrograde cholangiopancreatography , pancreatitis , pancreas , ablation , pancreatic duct , gastroenterology , surgery , acute pancreatitis , pancreatic disease , major duodenal papilla , cancer
Palliation of pancreatic cancer remains the only option for the majority of patients. Palliative techniques such as surgical bypass and endoscopic retrograde cholangiopancreatography (ERCP) with stenting are not ideal. The 'ideal' palliative technique would combine the efficacy of surgery with the minimal complications of an endoscopic procedure. Endoscopically delivered perductal electrolytic ablation of pancreatic lesions has the potential to meet these criteria.